echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > European Radiology: AI-based computer-aided diagnosis in mammography

    European Radiology: AI-based computer-aided diagnosis in mammography

    • Last Update: 2022-11-25
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    At this stage, mammogram is the standard way
    to screen and detect breast cancer.
    However, due to
    the inherent limitations of its two-dimensional projection, the sensitivity is low, between
    63% and 84%.
    Currently, AI-based computer-aided diagnostics (AI-CAD) are used in
    mammograms and have shown performance comparable to or higher than stand-alone diagnostics, while significantly improving the diagnostic performance
    of radiologists when used as an additional tool.
    Unlike traditional CAD programs based on features defined by radiologists, AI-CAD algorithms based on deep learning networks are less intuitive
    in deriving final scores or results.
    Since most commercial AI-CAD programs provide heat maps with anomaly scores, users generally accept that a higher score means a higher
    probability of cancer.
    However, the significance of the scores themselves has not been clarified, and questions remain
    about what different scores mean for patients, or how abnormal scores are related to the American Society of Radiology Breast Imaging and Reporting System (BI-RADS).

     

    Recently, a study published in the journal European Radiology evaluated the abnormality score of breast cancer based on clinical, radiological and pathological features, and analyzed the breast cancer characteristics of false-negative cases in AI-CAD, providing a reference for the technology to better assist radiologists and
    clinicians.

     

    This study included 930 people diagnosed with breast cancer from January 2017 to December 2017
    .
    Commercial AI-CAD was applied to
    mammography with an abnormal score
    .
    Abnormal scores
    were assessed based on clinical, radiological, and pathological features.
    A false-negative result is defined as an abnormal score of less than 10
    .

     

    The median abnormal score for 930 breasts was 87.
    4 (range 0-99).

    The false negative rate of AI-CAD is 19.
    4% (180/930).

    Compared with low-scoring cancers, cancers with an abnormal score of more than 90 showed a high proportion of palpable lesions, BI-RADS 4c and 5 lesions, masses presenting with or without microcalcifications, and invasive
    breast cancer (all P < 0.
    001
    ).
    False-negative breast cancer is more likely to occur in asymptomatic patients and dense breasts than detected breast cancer, and is diagnosed with occult breast cancer and DCIS
    .

     


    Figure:
    A 44-year-old patient diagnosed with a 20 mm sized triple-negative subtype invasive ductal carcinoma in the left breast with a stage of T1cN0
    .
    The left-sided breast cancer appears as a mass (arrow) at 1 o'clock, which is missed by AI-CAD (abnormal score 7).

     

    This study shows that high abnormal scores for breast cancer described on AI-CAD are associated
    with higher BI-RADS categories, invasive pathology, and higher malignancy grades.

     

    Original source:

    Si Eun Lee,Kyunghwa Han,Jung Hyun Yoon,et al.
    Depiction of breast cancers on digital mammograms by artificial intelligence-based computer-assisted diagnosis according to cancer characteristics.
    DOI:10.
    1007/s00330-022-08718-2

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.